Creative Medical Technology Holdings, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Creative Medical Technology Holdings, Inc. (CELZ) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -0.40% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-20.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-03-20
- Creative Medical Technology Holdings, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was -0.40%.
- Creative Medical Technology Holdings, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -0.40%.
- Creative Medical Technology Holdings, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -0.40%.
- Creative Medical Technology Holdings, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -0.20%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | -0.40% 10-K · filed 2026-03-20 | ||
| 2024-12-31 | -0.40% 10-K · filed 2026-03-20 | ||
| 2023-12-31 | -0.40% 10-K · filed 2025-03-14 | ||
| 2022-12-31 | -0.20% 10-K · filed 2024-03-22 | -0.30% 10-K · filed 2023-03-31 | |
| 2021-12-31 | -22.70% 10-K · filed 2023-03-31 | -23.80% 10-K · filed 2022-03-30 | |
| 2020-12-31 | -20.20% 10-K · filed 2022-03-30 | ||
| 2019-12-31 | -17.90% 10-K · filed 2021-03-17 | ||
| 2018-12-31 | -28.90% 10-K · filed 2020-04-06 | -28.90% 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |